News Posts

Order by:
<< | < | 1 2 3 4 5 6 7 | > | >>


Menstrual Blood Stem Cells Part 2

Tokyo, Japan -

It was previously reported by the company Medistem (mdsm.ob) that a population of multipotent stem cells exist in menstrual blood.  These cells, which Medistem termed "endometrial regenerative cells" appear to possess some of the properties of mesenchymal stem cells, such as expression of CD90 and...


Expanding Hematopoietic Stem Cells by Removing Inhibitors

The desire to expand hematopoietic stem cells is not only a basic research accomplishment but would allow for widespread use of autologous stem cells, as well as expand the utilization of cord blood stem cells which are usually of concern due to the relatively low stem cell content.

Various methods of expanding hematopoietic stem cells exist, for example, Sunday April 20th, 2008 @ 15:22:22 EST


"I need blood" says the embryoid body

Tokyo, Japan -

Embryonic stem cells have a very high potential to generate various tissues, a potential so high that it actually serves as a drawback in some senses.  See, embryonic stem cells, when grown in floating cultures form embryoid bodies, and in these embryoid bodies the embryonic stem cell starts differentiating into a wide...

Sunday April 13th, 2008 @ 15:39:22 EST

Stem Cell Cytokines Preventing Ischemia Reperfusion

Osaka, Japan -

Granulocyte colony stimulating factor (G-CSF) is one of the largest selling products of the biotechnology industry.  Approved uses of this recombinant cytokine include stimulation of neutrophil production after chemotherapy or bone marrow transplantation.  Another use is in mobilizing the hematopoietic stem cells to...


Treating back pain with mesenchymal stem cells

Pittsburgh, Pennsylvania -

Vertebral disc degeneration is a major cause of suffering internationally.  Although various interventions exist, such as disc replacement and surgical fusion, these have numerous long-term limitations such as need for resurgery, degeneration of the adjacent disc, and relapse of pain.  One exciting method of treating...

Saturday April 12th, 2008 @ 14:52:30 EST

Clinical trial for diabetes using autologous cord blood

Gainsville, Florida -

Autologous cord blood has received some recent media for its use in treatment of cerebral palsy.  Other groups have reported the use of allogeneic cord blood to have positive effects for conditions other than hematopoietic disorders, even in absence of immune...


Mesenchymal Stem Cells in the Eye

Hyderabad, India -

Mesenchymal stem cells are one of the most clinically advanced forms of stem cell therapy after hematopoietic stem cell transplantation.  The conventional source for mesenchymal stem cells has been bone marrow, however these cells can also be extracted from a variety of other tissues such as teethSunday March 30th, 2008 @ 20:24:11 EST


Medistem's New Stem Cell Type Wins Award

SCOTTSDALE, AZ--(MARKET WIRE)--Mar 20, 2008 -- Medistem Laboratories, Inc. (OTC BB:MDSM.OB - News) is pleased to announce its recent co-authored article entitled, "Endometrial regenerative cells: a novel stem cell population" received BioMed Central's research article of the year in medicine award. The award recognizes excellence...

Sunday March 23rd, 2008 @ 19:28:19 EST

Fetal cells home to injured mother tissue

The current accepted method of using cord blood is for post myeloablative hematopoietic reconstitution in patients with leukemias, or other hematological/metabolic disorders. Essentially the idea is that if you destroy the resident stem cells and administer "healthy" stem cells, then the progeny of the healthy stem cells will act in a dominant manner to reverse the disease. Many clinicians...

Wednesday March 19th, 2008 @ 09:43:08 EST

Turning on healthy stem cells, turning off leukemia

Sydney, Australia - The signals that control proliferation of hematopoietic stem cells are still relatively unknown. Not only is the study of the hematopoietic stem cell important because it is one of the most well characterized stem cell systems, but also it has some very strong practical implications in terms of treating disease. For example, hematopoietic toxicity is often the...

Wednesday March 12th, 2008 @ 02:38:49 EST

Order by:
<< | < | 1 2 3 4 5 6 7 | > | >>





Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2008 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.01